CL2011000713A1 - Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos. - Google Patents

Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.

Info

Publication number
CL2011000713A1
CL2011000713A1 CL2011000713A CL2011000713A CL2011000713A1 CL 2011000713 A1 CL2011000713 A1 CL 2011000713A1 CL 2011000713 A CL2011000713 A CL 2011000713A CL 2011000713 A CL2011000713 A CL 2011000713A CL 2011000713 A1 CL2011000713 A1 CL 2011000713A1
Authority
CL
Chile
Prior art keywords
imidacloprid
pharmaceutical composition
subtoxic
systematic control
oral
Prior art date
Application number
CL2011000713A
Other languages
English (en)
Inventor
Roland H Johnson
Douglas I Hepler
Kathleen G Palma
Wilians R Campbell
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of CL2011000713A1 publication Critical patent/CL2011000713A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica de un antiparasitario de imidacloprid para el tratamiento de pulgas en mamíferos.
CL2011000713A 2008-10-03 2011-03-31 Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos. CL2011000713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10277408P 2008-10-03 2008-10-03

Publications (1)

Publication Number Publication Date
CL2011000713A1 true CL2011000713A1 (es) 2011-08-26

Family

ID=42073871

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000713A CL2011000713A1 (es) 2008-10-03 2011-03-31 Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.

Country Status (28)

Country Link
US (2) US9820977B2 (es)
EP (1) EP2349265B1 (es)
JP (3) JP6110065B2 (es)
KR (3) KR20110067048A (es)
CN (2) CN107041887A (es)
AU (1) AU2009298541B2 (es)
BR (1) BRPI0920434B1 (es)
CA (1) CA2736263C (es)
CL (1) CL2011000713A1 (es)
CO (1) CO6361913A2 (es)
DK (1) DK2349265T3 (es)
EC (1) ECSP11011023A (es)
ES (1) ES2588152T3 (es)
HR (1) HRP20161082T1 (es)
HU (1) HUE030412T2 (es)
IL (1) IL211624B (es)
MX (1) MX2011003415A (es)
NI (1) NI201100067A (es)
NZ (1) NZ592010A (es)
PE (1) PE20110395A1 (es)
PL (1) PL2349265T3 (es)
PT (1) PT2349265T (es)
RU (1) RU2526169C2 (es)
SI (1) SI2349265T1 (es)
SV (1) SV2011003871A (es)
UA (1) UA102565C2 (es)
WO (1) WO2010039892A1 (es)
ZA (1) ZA201102077B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130035303A1 (en) * 2010-04-22 2013-02-07 Genesis Laboratories, Inc. Compositions and methods for control of sand flies and other blood sucking insects
CA2780119A1 (en) * 2011-06-16 2012-12-16 Daniel Kouri Capsule for oral pet medicine
AU2013245011B2 (en) * 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3389628A4 (en) 2015-12-19 2019-08-07 Dixit, Manesh A. PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
EP3532041A4 (en) * 2016-10-31 2020-06-24 The Scripps Research Institute METHOD AND COMPOSITIONS FOR PREVENTING VECTOR-INDUCED DISEASE TRANSMISSION
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP3820870A1 (en) 2018-07-09 2021-05-19 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
KR102659363B1 (ko) 2020-05-26 2024-04-22 주식회사 경보제약 동물에서의 기생충 감염 질환을 치료 또는 예방하기 위한 수의학적 구강붕해필름 제제
JP2023528822A (ja) 2020-05-29 2023-07-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性複素環式化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419814A1 (de) * 1994-06-07 1995-12-14 Bayer Ag Endoparasitizide
US6140350A (en) 1998-06-08 2000-10-31 Sumitomo Chemical Company, Limited Method for controlling ectoparasites
JP4538863B2 (ja) * 1998-06-08 2010-09-08 住友化学株式会社 寄生虫の駆除方法
JP2000062271A (ja) 1998-08-17 2000-02-29 Murata Mach Ltd 記録装置
BR0013116B1 (pt) 1999-08-12 2013-01-22 formulaÇÕes orais de dose énica para controlar infestaÇço por ectoparasita em animais de estimaÇço, e seu uso.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
JP4972843B2 (ja) 2000-11-09 2012-07-11 住友化学株式会社 動物外部寄生虫防除用経皮投与剤
CN1386420A (zh) 2001-05-22 2002-12-25 王玉万 一种含吡虫啉的宠物用抗寄生虫药
UA80096C2 (en) 2001-07-05 2007-08-27 Mikkel Sa Fencing for preventing insects to enter
JP2005515215A (ja) 2001-12-21 2005-05-26 ローディア インコーポレイティド 成分を懸濁させるための安定な界面活性剤組成物
US7943160B2 (en) 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
MXPA05012791A (es) 2003-05-25 2006-02-22 Wang Yuwan Formulacion sostenida que contiene dimeticona.
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
MX2007005617A (es) 2004-11-11 2007-07-09 Merial Ltd Derivados de vinilaminopirazol como pesticidas.
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
MX2007008837A (es) 2005-01-21 2008-01-22 Merial Ltd Compuestos quimicos, procesos para su preparacion y uso de los mismos.
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds

Also Published As

Publication number Publication date
EP2349265A4 (en) 2012-10-24
RU2526169C2 (ru) 2014-08-20
PL2349265T3 (pl) 2017-01-31
KR101787917B1 (ko) 2017-10-18
HUE030412T2 (hu) 2017-05-29
ES2588152T3 (es) 2016-10-31
RU2011117203A (ru) 2012-11-10
KR20110067048A (ko) 2011-06-20
BRPI0920434B1 (pt) 2021-07-27
JP2012504636A (ja) 2012-02-23
AU2009298541A1 (en) 2010-04-08
KR101903313B1 (ko) 2018-10-01
JP2018127468A (ja) 2018-08-16
EP2349265B1 (en) 2016-05-25
DK2349265T3 (en) 2016-09-05
BRPI0920434A2 (pt) 2015-12-22
MX2011003415A (es) 2011-08-12
SV2011003871A (es) 2011-08-22
AU2009298541B2 (en) 2015-03-26
PE20110395A1 (es) 2011-06-19
IL211624A0 (en) 2011-05-31
NZ592010A (en) 2012-07-27
ZA201102077B (en) 2012-12-27
US20100087492A1 (en) 2010-04-08
CO6361913A2 (es) 2012-01-20
ECSP11011023A (es) 2011-06-30
EP2349265A1 (en) 2011-08-03
JP2016179983A (ja) 2016-10-13
CA2736263A1 (en) 2010-04-08
JP6388890B2 (ja) 2018-09-12
WO2010039892A8 (en) 2011-03-24
HRP20161082T1 (hr) 2016-10-21
CN107041887A (zh) 2017-08-15
IL211624B (en) 2018-01-31
UA102565C2 (ru) 2013-07-25
CA2736263C (en) 2020-01-14
US9820977B2 (en) 2017-11-21
KR20160011711A (ko) 2016-02-01
JP6110065B2 (ja) 2017-04-05
CN102170880A (zh) 2011-08-31
KR20170118235A (ko) 2017-10-24
SI2349265T1 (sl) 2016-10-28
NI201100067A (es) 2012-03-15
WO2010039892A1 (en) 2010-04-08
PT2349265T (pt) 2016-08-31
US20180078537A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
CL2011000713A1 (es) Composicion farmaceutica antiparasitaria oral subtoxica de imidacloprid para el control sistemico de parasitos hematofagos.
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
ATE528989T1 (de) Kristalline feste rasagilin-base
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
BRPI0810936A2 (pt) Composto, composição para controlar uma praga de invertebrados e método para proteger um animal de uma praga parasítica deinvertebrados
CL2007003341A1 (es) Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras.
ECSP11011054A (es) Péptidos antivirales terapéuticos
CR11264A (es) Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
CR20120008A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CL2015000462A1 (es) Composición fungicida y método para el control de las enfermedades de las plantas.
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
BRPI0914410A2 (pt) composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares.
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CL2008001728A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
CL2009000904A1 (es) Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
CR11368A (es) Forma cristalina 1 de 2- ( (r)-2-metilpirrolidin-2-il) -1h-benzimidazol-4-carboxamida
CL2009000294A1 (es) Compuestos derivados de heterociclos aril metilideno; composicion farmaceutica que los comprende; y uso en el tratamiento del dolor neuropatico e inflamacion.